Canada's Green Rush: Bringing Cannabis Health Products to Market, New Webinar Hosted by Xtalks
TORONTO, December 20, 2018 (Newswire.com) - Join industry experts from KGK Science Inc., Najla Guthrie, President/CEO and Andrew Charrette, Senior Manager of Regulatory Affairs, for a live webinar on Tuesday, January 15, 2019 at 1pm EST.
Canada’s green rush is now in full effect. With legalization of recreational use now approved in Canada, and the medicinal market continuing to grow and mature in North America, opportunities for health products or products containing cannabis requires appropriate product planning steps for securing a competitive advantage.
Join this webinar to hear from expert speakers on key topics affecting the Canadian cannabis industry today, including:
- Areas of expertise required for successful path to market
- Navigating current & anticipated regulations in Canada & USA
- Successful product development strategies
- Research requirements for claims substantiation in North America
For more information or to register for this event, visit Canada’s Green Rush: Bringing Cannabis Health Products to Market.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Tel: +1 (416) 977-6555 ext 224
Categories: Pharmaceuticals and Biotech
Tags: Cannabis, Claims Substantiation, Clinical Trials, Drug Discovery and Development, KGK Science, Life Sciences, Nutraceuticals, Pharmaceutical, Pharmaceutical Regulation, Regulatory Affairs, Xtalks